about
Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the ratReduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar ConsumptionDeuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex.Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine.Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.
P50
Q35179053-7707AB94-59F7-4984-9FAF-468C8CA74F1FQ36152395-9B811375-57C7-4030-8589-ED9C52831F8AQ42705333-D4FD123D-64DB-48F9-959B-F5105C4B623CQ44522087-F2CE23D2-C3A3-45CD-BD60-AF03FEBB3C9CQ45094374-E42CE53E-4FD0-4795-836B-E30AB9E9235FQ45937388-32D12945-596B-4865-9C13-8FFFA81F56E8Q46947142-0A4BDC0E-0DF5-4469-A927-F42272B61AA2Q50062569-9346A253-B00F-4711-AC46-8EE7ECF14178
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Asa Konradsson
@en
Asa Konradsson
@nl
type
label
Asa Konradsson
@en
Asa Konradsson
@nl
prefLabel
Asa Konradsson
@en
Asa Konradsson
@nl
P31
P496
0000-0002-8739-9645